What’s going on here? Intel’s next-generation manufacturing process failed its test, calling the tech firm’s know-how into question. What does this mean? Intel’s “18A” manufacturing process was supposed to show that old dogs can, in fact, learn new tricks. But despite spending years developing the tech, the American firm is yet to prove the old adage wrong. After checking out semiconductor parts produced by Intel’s machines, chip designer Broadcom has said the process isn’t fit for mass production yet. This is just the latest knock for the legacy tech firm’s confidence. Intel announced a $1.6 billion loss last quarter, stopped its dividend, and predicted 15,000 job cuts – so the stock has been laying low. Plus, the firm had to ditch plans to partner with Softbank on a Nvidia-esque chip, unable to meet the Japanese company’s production demands. Why should I care? For markets: Intel’s shooting for Nvidia, but the stars would do. Good news: the US government approved funding for the Chips Act in March, which would hand Intel almost $20 billion in grants and loans. Bad news: it’ll only be paid out if the firm lives up to lenders’ lofty expectations. So Intel could be left empty-handed if it falls behind, potentially derailing the company’s plans to throw money into infrastructure and development in a bid to catch up to Nvidia. The bigger picture: You can’t win ‘em all. Intel’s bigwigs will need to formulate their next steps wisely at this month’s board meeting. See, if the firm cuts costs by scaling back US factories, the Chips Act award would almost certainly be pared back, too. But do nothing, and Intel might not see a cent anyway. This one will be a risky call for investors, not least because it can be years until a recovery strategy is deemed a success or failure. So assessing Intel’s chances may be best left to the industry experts. |